The Pershing Square Sohn Prize for Young Investigators in Cancer Research provides New York area-based early career scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking. Prize winners each receive $200,000 a year for up to three years. At least six prizes are awarded annually.
The Pershing Square Sohn Cancer Research Alliance (PSSCRA) is dedicated to accelerating cures for cancer by advancing the pursuit of innovative cancer research and by facilitating collaborations between the science and business communities. PSSCRA seeks to guide philanthropic funds to feed critical scientific discoveries, attracting like-minded investors to the cause of fighting cancer and creating a pipeline for early-stage biomedical investments.
In addition to receiving funding, Prize winners are given access to a unique network and are invited to participate in select programs, including:
- Facilitated partnerships with other researchers within and across institutions
- Networking programs (including: collaborations/discussions amongst Prize winners and industry mentors, introductions to philanthropic and for-profit investors in the business community, and invitations to special industry networking and entrepreneurship events)
- Annual retreat and symposium
- Ability to present the best ideas at conferences and events (hosted by PSSCRA and other organizations)